Literature DB >> 4001442

The radiobiology of human neuroblastoma.

J M Deacon, P A Wilson, M J Peckham.   

Abstract

The radiation response of a human neuroblastoma xenograft HX138 has been studied in vitro and in vivo using single cells in suspension, multicellular spheroids, and xenografts in immune-suppressed mice. End-points used were growth delay and clonogenic cell survival. Growth delay experiments with spheroids and xenografts showed a high degree of radioresponsiveness. Cell survival curves obtained from all systems were characterised by the lack of a shoulder. An increase in Do of the cell survival curve was seen after irradiation of intact spheroids and xenografts, perhaps due to the presence of a contact effect. Cellular capacity for split-dose recovery in vitro was modest. Delayed assay experiments using spheroids and xenografts showed some potentially lethal damage (PLD) repair in vitro but not in vivo. The results show this human tumour line to be intrinsically highly radiosensitive, with a limited repair capacity.

Entities:  

Mesh:

Year:  1985        PMID: 4001442     DOI: 10.1016/s0167-8140(85)80029-3

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

1.  Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.

Authors:  Brian H Kushner; Nai-Kong V Cheung; Christopher A Barker; Kim Kramer; Shakeel Modak; Karima Yataghene; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-08       Impact factor: 7.038

Review 2.  Targeted radiotherapy for neuroblastoma.

Authors:  S Meller
Journal:  Arch Dis Child       Date:  1997-11       Impact factor: 3.791

3.  Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial.

Authors:  Dana L Casey; Brian H Kushner; Nai-Kong V Cheung; Shakeel Modak; Ellen M Basu; Stephen S Roberts; Michael P LaQuaglia; Suzanne L Wolden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-11       Impact factor: 7.038

4.  Host cell reactivation of gamma-irradiated adenovirus 5 in human cell lines of varying radiosensitivity.

Authors:  J J Eady; J H Peacock; T J McMillan
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

5.  Micronucleus formation in human tumour cells: lack of correlation with radiosensitivity.

Authors:  C Bush; T J McMillan
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

6.  Growth and radiosensitivity testing of human tumour cells using the adhesive tumour cell culture system.

Authors:  C S Parkins; G G Steel
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

7.  Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE.

Authors:  Javian C Malcolm; Nadia Falzone; Jennifer E Gains; Matthew D Aldridge; David Mirando; Boon Q Lee; Mark N Gaze; Katherine A Vallis
Journal:  EJNMMI Phys       Date:  2022-03-28

8.  Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours.

Authors:  E K Rofstad; R M Sutherland
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

9.  High intrinsic radiosensitivity of a newly established and characterised human embryonal rhabdomyosarcoma cell line.

Authors:  L R Kelland; L Bingle; S Edwards; G G Steel
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

10.  Glutathione determination by the Tietze enzymatic recycling assay and its relationship to cellular radiation response.

Authors:  J J Eady; T Orta; M F Dennis; M R Stratford; J H Peacock
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.